IN DEPTHNarrow FDA vote on Merck’s molnupiravir bolsters outlook on mAbsCan drug repurposing uncover better treatments for UTIs?Lethal injection: can pharma kill the death penalty?Pharmacovigilance The challenges of multiple drugs safety reportingSafety reporting for treatments involving multiple drugs must improve to protect patients from harmful drug-drug interactionsPRICNGPfizer and Takeda deals put a spotlight on value-based pricingMANUFACTURING3D printing in drug manufacturing: unlocking future possibilitiesNarrow FDA vote on Merck’s molnupiravir bolsters outlook on mAbsCan drug repurposing uncover better treatments for UTIs?Lethal injection: can pharma kill the death penalty?02/24/2024 03:29:02
Narrow FDA vote on Merck’s molnupiravir bolsters outlook on mAbs
Can drug repurposing uncover better treatments for UTIs?
Lethal injection: can pharma kill the death penalty?